Tumor Susceptibility Gene 101 (TSG101) Peptid
TSG101
Reaktivität: Human, Maus
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle TSG101 Produkte
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
- Spezies
- Human, Maus
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-TSG101 antibody (Catalog #: ARP37310_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
- Hintergrund
-
TSG101 has a direct role in the control of growth and differentiation in primary epithelial cells. It is required for normal cell function of embryonic and adult tissues but that this gene is not a tumor suppressor for sporadic forms of breast cancer.
Alias Symbols: CC2, AI255943
Protein Interaction Partner: Gmcl1
Protein Size: 391 - Molekulargewicht
- 43 kDa
- Gen-ID
- 22088
- NCBI Accession
- NM_021884, NP_068684
- UniProt
- Q61187
-
Sie sind hier:
